Recorded fact · drug.label_indication
drug.label_indication for atogepant|migraine
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 5bc48e15 resolves to.
The record
| Fact id | 5bc48e158a68106d8ff90637 |
|---|---|
| Entity | drug: atogepant|migraine |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250930 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
QULIPTA is indicated for the preventive treatment of migraine in adults.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 8811a871c249bb08a42c5545cb631a8a956e28622c90d6fbde0dafc101171a4a.
The value
{
"ingredient": "Atogepant",
"conditionId": "migraine",
"conditionName": "Migraine",
"matchedAlias": "migraine",
"context": "indication",
"brand": "Qulipta",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "8c8ab8f4-32bd-497a-befa-70c8a51d8d52",
"labelEffectiveTime": "20250930",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 7744fc71c3ab81044492c04637a2753c5188b0c3d61b9c9116855b6ac082b956.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.